<VariationArchive RecordType="classified" VariationID="13834" VariationName="GLI2, 1-BP DEL, NT2274" VariationType="Deletion" Accession="VCV000013834" Version="3" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-03-18" DateCreated="2014-06-23" MostRecentSubmission="2023-03-18">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="28873" VariationID="13834">
      <GeneList>
        <Gene Symbol="GLI2" FullName="GLI family zinc finger 2" GeneID="2736" HGNC_ID="HGNC:4318" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>2q14.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="120735868" stop="120992653" display_start="120735868" display_stop="120992653" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="121554866" stop="121750228" display_start="121554866" display_stop="121750228" Strand="+" />
          </Location>
          <OMIM>165230</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GLI2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GLI2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>GLI2, 1-BP DEL, NT2274</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q14</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>1-BP DEL, NT2274</Name>
      </OtherNameList>
      <XRefList>
        <XRef Type="Allelic variant" ID="165230.0001" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="GLI2, 1-BP DEL, NT2274 AND Holoprosencephaly 9" Accession="RCV000014846" Version="24">
        <ClassifiedConditionList TraitSetID="3820">
          <ClassifiedCondition DB="MedGen" ID="C1835819">Holoprosencephaly 9</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2010-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2010-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2014-06-23" MostRecentSubmission="2023-03-18">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14581620</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15994174</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20685856</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3820" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5262" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES</ElementValue>
                <XRef Type="MIM" ID="610829" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES</ElementValue>
                <XRef Type="MIM" ID="610829" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Holoprosencephaly 9</ElementValue>
                <XRef ID="Holoprosencephaly+9/8564" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012563" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPE9</ElementValue>
                <XRef Type="MIM" ID="610829" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301702</ID>
                <ID Source="BookShelf">NBK1530</ID>
              </Citation>
              <XRef ID="2162" DB="Orphanet" />
              <XRef ID="C1835819" DB="MedGen" />
              <XRef ID="MONDO:0012563" DB="MONDO" />
              <XRef Type="MIM" ID="610829" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="35101" SubmissionDate="2021-12-13" DateLastUpdated="2023-03-18" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="165230.0001_HOLOPROSENCEPHALY 9" title="GLI2, 1-BP DEL, NT2274_HOLOPROSENCEPHALY 9" />
        <ClinVarAccession Accession="SCV000035101" DateUpdated="2023-03-18" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members in 4 successive generations of a family with pituitary anomalies with holoprosencephaly-like features (HPE9; 610829), Roessler et al. (2003) identified heterozygosity for a 1-bp deletion at nucleotide 2274 in the GLI2 gene. The disorder was transmitted through unaffected mutation carriers. A deceased male in the first generation was reported to have had cleft lip and palate in addition to polydactyly. The proband in the fourth generation had midface hypoplasia, repaired cleft lip and palate, postaxial polydactyly, and absent pituitary on MRI associated with panhypopituitarism. Male twin brothers of the female proband had panhypopituitarism. One died at age 5 months with midline cleft lip and palate, hypotelorism, flat midface, absent pituitary, and partial agenesis of the corpus callosum. The father and paternal aunt of the proband (in the third generation) had normal intelligence and postaxial polydactyly that may represent a microform. The 1-bp deletion was identified in the proband, the surviving twin brother, the father, and the paternal aunt.</Attribute>
              <Citation>
                <ID Source="PubMed">14581620</ID>
              </Citation>
              <XRef DB="OMIM" ID="610829" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In vitro functional expression studies by Roessler et al. (2005) showed that the 2274del1 mutation resulted in a dominant-negative effect when coexpressed with wildtype GLI2.</Attribute>
              <Citation>
                <ID Source="PubMed">15994174</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Franca et al. (2010) referred to this mutation as Tyr1086fsTer42.</Attribute>
              <Citation>
                <ID Source="PubMed">20685856</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GLI2" />
          </GeneList>
          <Name>GLI2, 1-BP DEL, NT2274</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, NT2274</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="165230.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HOLOPROSENCEPHALY 9</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="35101" TraitType="Disease" MappingType="Name" MappingValue="HOLOPROSENCEPHALY 9" MappingRef="Preferred">
        <MedGen CUI="C1835819" Name="Holoprosencephaly 9" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

